Exenatide

Both are exenatide, but the delivery differs. Byetta is immediate-release and injected twice daily within 60 minutes before the morning and evening meals. Bydureon packages the same peptide into slow-dissolving microspheres, so a single 2mg injection lasts a full week. DURATION-1 found the once-weekly version produced slightly greater HbA1c reduction than twice-daily dosing, with fewer injections.

Semaglutide is substantially more effective. Exenatide produces around 2-3 kg of weight loss and modest HbA1c reduction, while semaglutide delivers roughly 15% body weight reduction in the STEP trials plus larger glucose improvements. Semaglutide's ~7-day half-life also allows once-weekly dosing without the microsphere technology Bydureon relies on. For most people, exenatide has been eclipsed by semaglutide and tirzepatide.

Yes. Exendin-4, the peptide exenatide is copied from, was isolated in 1992 from the venom of the Gila monster, a venomous lizard native to the southwestern United States and Mexico [1]. Researchers noticed the reptile could go long stretches between meals, and the peptide in its venom turned out to activate the human GLP-1 receptor while resisting the enzyme that rapidly degrades native GLP-1. The commercial drug is fully synthetic. No lizards are involved in manufacturing.

Byetta has a short half-life of about 2.4 hours, which is why it needs twice-daily injections timed to meals. Bydureon sidesteps this with an extended-release microsphere formulation that steadily releases exenatide over a week, allowing once-weekly dosing despite using the same underlying peptide.

Exenatide is an FDA-approved prescription medication, first cleared in 2005. It is a legitimate diabetes drug, not a research chemical. That said, it is prescribed far less often now that semaglutide, tirzepatide, and dulaglutide offer greater efficacy with once-weekly dosing, and its manufacturer has wound down some formulations. Treat it as a historically important first-in-class agent rather than a current go-to.

Both forms are subcutaneous injections into the abdomen, thigh, or upper arm. Byetta starts at 5mcg twice daily for the first month, then increases to 10mcg twice daily, each dose given within 60 minutes before a meal. Bydureon is a fixed 2mg dose once weekly on the same day each week. Neither is meant for intravenous or intramuscular use.